Arrowstreet Capital’s Seagen Inc. Common Stock SGEN Stock Holding History

Arrowstreet Capital’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-84,974	Closed	-$11.8M	–	2315
2021 Q1	$11.8M	Buy	84,974 +62,274	+274%	+$10M	0.02%	812
2020 Q4	$3.98M	Buy	+22,700	New	+$4.23M	0.01%	1311
2020 Q3	–	Sell	-1,461	Closed	-$248K	–	2581
2020 Q2	$248K	Buy	+1,461	New	+$218K	﹤0.01%	2141
2020 Q1	–	Sell	-39,986	Closed	-$4.57M	–	2186
2019 Q4	$4.57M	Buy	+39,986	New	+$4.24M	0.01%	881
2017 Q3	–	Sell	-40,200	Closed	-$2.08M	–	1277
2017 Q2	$2.08M	Buy	40,200 +2,500	+7%	+$159K	0.01%	649
2017 Q1	$2.37M	Buy	+37,700	New	+$2.35M	0.01%	762
2016 Q4	–	Sell	-120,545	Closed	-$6.51M	–	2627
2016 Q3	$6.51M	Buy	+120,545	New	+$5.72M	0.02%	574
2014 Q3	–	Sell	-22,471	Closed	-$860K	–	1149
2014 Q2	$860K	Buy	+22,471	New	+$850K	﹤0.01%	741
2013 Q4	–	Sell	-108,028	Closed	-$4.74M	–	1319
2013 Q3	$4.74M	Buy	108,028 +58,266	+117%	+$2.43M	0.03%	396
2013 Q2	$1.57M	Buy	+49,762	New	+$1.74M	0.01%	493

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arrowstreet Capital's SGEN Position: Q2 2021 in Review

Arrowstreet Capital sold out of Seagen Inc. Common Stock (SGEN) in Q2 2021, closing a stake of 84,974 shares — an estimated $11.8M sold.

Arrowstreet Capital first reported a position in SGEN in Q2 2013 and held it in 10 quarters. The position peaked at $11.8M in Q1 2021. 477 funds tracked by Wall St. Rank hold SGEN as of Q2 2021.

Arrowstreet Capital reported no remaining Seagen Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Arrowstreet Capital sold 84,974 Seagen Inc. Common Stock shares in Q2 2021, an estimated $11.8M.
Arrowstreet Capital first reported a position in Seagen Inc. Common Stock in Q2 2013 and held it in 10 quarters.
Arrowstreet Capital's Seagen Inc. Common Stock position peaked at $11.8M in Q1 2021.
477 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2021.

Based on Arrowstreet Capital's 13F filing for Q2 2021, filed 13 Aug 2021.